Every time it comes back up it gets beaten down. We are right at the 2009 levels. You have a place to hang your hat here. If it is breaking down here there are bigger problems with this one. You are probably going to get some kind of a dividend cut announcement which the market has already discounted. Expect some volatility.

He likes it here. It has lows in August and September. Maybe it is going to get to $9.40-$9.50. It broke the steep downtrend and is probably going to go sideways for a while.

They are a safe way to play the bounce back. Third quarter results were in line. There is capital spending increasing modestly. The dividend is increasing modestly. He just picked this one up. It has a nice trend. (Analysts’ price target is $55.81)

It is the most amazing stock. They reported a no-surprise quarter. They just made an acquisition. It has recovered really nicely since July. It is a good core holding. It is fairly tightly held. (Analysts’ price target is $63.07)

They specialize in serious diseases. It is volatile. You could just own the XBB-T. He thinks our life span is going to expand significantly and these guys are going to be part of it. (Analysts’ price target is $226.45)

Executed brilliantly. Alternative lender. Loan book over 1B dollars. A lot of future growth already built in. Be careful, if there's a recession, they can get hit hard. But he doesn't see that on the horizon.

Still likes it. Executed really well in their space. Just paid a special dividend. He's hoping for an acquisition. Reasonably priced. Plowing money back into R&D to make broadcasting easier.